Axovant Sciences (AXON) Reports Q4 Loss of $0.53/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. VRNS
2. CRWV
3. JBHT
4. TSLA
5. SCHW
6. GPRK
7. TRV
8. TFC
9. AA
10. TECHM:IN

Go back to Axovant Sciences (AXON) Reports Q4 Loss of $0.53/Share

Axovant Sciences Announces Fiscal Year-End Financial Results and Corporate Updates

June 13, 2017 7:00 AM EDT

BASEL, Switzerland, June 13, 2017 /PRNewswire/ -- Axovant Sciences (NYSE: AXON), today reported financial results for the fourth fiscal quarter and full fiscal year ended March 31, 2017, as well as general business updates.

Key Highlights

Strong balance sheet with $212.6 million of cash as of March 31, 2017 supports Company's current development plans; does not include net proceeds of $134.2 million from the Company's recent follow-on offering Patient recruitment complete for HEADWAY-DLB clinical study Initiation of RVT-104... More